Clover Health Reports Cybersecurity Incident, Enhances Protections
I'm LongbridgeAI, I can summarize articles.Clover Health reported a cybersecurity incident on July 4, 2026, where social engineering led to unauthorized access to three employee accounts containing personal and health data. The company contained the breach, engaged experts, and does not expect material financial impact. Concurrently, TipRanks launched the RANK ETF tracking its US Momentum Analysts Index. Analysts maintain a Hold rating for CLOV with a $4.75 target, citing improving fundamentals but valuation risks.
TipRanks Welcomes a New ETF – NYSE:RANK
- TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
- RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.
Clover Health Investments ( (CLOV) ) has issued an update.
On July 4, 2026, Clover Health detected anomalous login activity in certain information systems and triggered its incident response, engaging third-party cybersecurity experts and notifying law enforcement. An investigation found that a threat actor, using social engineering, accessed three non-managerial employee accounts tied to member visit-scheduling and broker-facing sales, which contained some personal and health data but no corporate financial or claims systems.
The company reports that its rapid response contained and terminated the unauthorized access and, based on current information, does not expect a material impact on its business, financial condition, or results of operations. Clover Health is hardening its IT environment, continuing its investigation into the scope of the data exposure, and assessing regulatory and legal notification obligations, including communication with affected members.
The most recent analyst rating on (CLOV) stock is a Hold
with a $4.75 price target.
To see the full list of analyst forecasts on Clover Health Investments stock,
see the CLOV Stock Forecast page.
Spark’s Take on CLOV Stock
According to Spark, TipRanks’ AI Analyst, CLOV is a Neutral.
CLOV scores as moderately attractive primarily due to improving fundamentals (positive operating/free cash flow and a low-debt balance sheet) and strong technical momentum (price above key moving averages with positive MACD). The score is held back by weaker valuation signals (negative P/E and no dividend yield provided) and remaining execution risks highlighted in the earnings commentary (notably outpatient utilization and Part D/risk adjustment variability).
To see Spark’s full report on CLOV stock,
click here.
More about Clover Health Investments
Clover Health Investments Corp. operates in the health insurance sector, focusing on technology-enabled Medicare Advantage and related health plans. The company’s services center on managing member care, visit scheduling, and broker-facing sales activities, with a strong emphasis on handling personally identifiable and protected health information within its IT systems.
Average Trading Volume: 7,823,944
Technical Sentiment Signal: Buy
Current Market Cap: $2.32B
For a thorough assessment of CLOV stock, go to TipRanks’ Stock Analysis page.